13F Filings History of RENAISSANCE TECHNOLOGIES LLC

Latest 13F report
Q4 2025 - 12 Feb 2026
Value $
$64,461,244,358
Notable people
Jim Simons, Robert Mercer, Peter Brown
Signature - Title
Tiffany Michel - Chief Compliance Officer
Location
New York, NY
Summary
This page shows a list of all the recent 13F filings made by RENAISSANCE TECHNOLOGIES LLC. Form 13F is required to be filed within 45 days of the end of a calendar quarter. RENAISSANCE TECHNOLOGIES LLC reported 3184 stock holdings with total value $64,461,244,358 as of Q4 2025. Top holdings included PALANTIR TECHNOLOGIES INC, UNITED THERAPEUTICS CORP DEL, MICRON TECHNOLOGY INC, KINROSS GOLD CORP, and VERISIGN INC.

Follow Filing Activity

Follow RENAISSANCE TECHNOLOGIES LLC and return when a new 13F portfolio filing changes the record on this page.

This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean. If you create an account from here, we will bring you back after verification.

Create free account and return here Already have an account? Sign in and return here
Holdings Value

Quick Takeaways

  • RENAISSANCE TECHNOLOGIES LLC reports institutional holdings through Form 13F filings.
  • Latest reported quarter: Q4 2025.
  • Latest reported holdings value: $64,461,244,358.

What Changed

  • Most recent filing was accepted on 12 Feb 2026, 14:24.
  • Reported value moved from $75,753,182,516 to $64,461,244,358.

Why This Matters

  • This gives a plain-language read of holdings direction before you open full quarter tables.
  • Use the filing links below to verify the exact SEC source document.

Source Evidence

Backed by Form 13F

Portfolio holdings and changes are grounded in SEC Form 13F filings.

See Original Filing
Quarter Holdings Value $ Bought Sold Net Top Holdings Form Type Filing Time
Q4 2025 3,184 $64,461,244,358 +$14,563,754,901 -$25,036,262,194 -$10,472,507,293 PALANTIR TECHNOLOGIES INC, UNITED THERAPEUTICS CORP DEL, MICRON TECHNOLOGY INC, KINROSS GOLD CORP, VERISIGN INC 13F-HR 12 Feb 2026, 14:24
Q3 2025 3,456 $75,753,182,516 +$15,349,487,698 -$21,318,933,034 -$5,969,445,336 PALANTIR TECHNOLOGIES INC, NVIDIA CORPORATION, ROBLOX CORP, UNITED THERAPEUTICS CORP DEL, VERISIGN INC 13F-HR 13 Nov 2025, 14:18
Q2 2025 3,522 $75,171,481,593 +$19,917,920,861 -$17,804,238,448 +$2,113,682,413 PALANTIR TECHNOLOGIES INC, NVIDIA CORPORATION, ROBINHOOD MKTS INC, VERISIGN INC, NETFLIX INC 13F-HR 13 Aug 2025, 15:37
Q1 2025 3,406 $66,072,250,548 +$15,160,099,710 -$15,512,487,564 -$352,387,854 PALANTIR TECHNOLOGIES INC, VERISIGN INC, CORCEPT THERAPEUTICS INC, ROBINHOOD MKTS INC, SPROUTS FMRS MKT INC 13F-HR 14 May 2025, 15:11
Q4 2024 3,533 $67,553,776,837 +$13,350,853,342 -$14,233,634,864 -$882,781,522 PALANTIR TECHNOLOGIES INC, UNITED THERAPEUTICS CORP DEL, NOVO-NORDISK A S, APPLE INC, VERISIGN INC 13F-HR 13 Feb 2025, 09:38
Q3 2024 3,484 $66,497,322,888 +$15,607,650,124 -$12,080,968,113 +$3,526,682,011 PALANTIR TECHNOLOGIES INC, NOVO-NORDISK A S, UNITED THERAPEUTICS CORP DEL, APPLE INC, VERTEX PHARMACEUTICALS INC 13F-HR 13 Nov 2024, 14:21
Q2 2024 3,443 $58,958,710,563 +$12,009,356,868 -$10,545,945,256 +$1,463,411,612 NOVO-NORDISK A S, PALANTIR TECHNOLOGIES INC, NVIDIA CORPORATION, VERTEX PHARMACEUTICALS INC, UNITED THERAPEUTICS CORP DEL 13F-HR 09 Aug 2024, 16:10
Q1 2024 3,657 $63,623,687 +$12,072,656 -$17,691,527 -$5,618,871 NOVO-NORDISK A S, PALANTIR TECHNOLOGIES INC, META PLATFORMS INC, AIRBNB INC, AMAZON COM INC 13F-HR 13 May 2024, 16:35
Q4 2023 3,682 $64,606,784 $0 $0 $0 NOVO-NORDISK A S, UBER TECHNOLOGIES INC, NVIDIA CORPORATION, PALANTIR TECHNOLOGIES INC, META PLATFORMS INC 13F-HR 13 Feb 2024, 11:29
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .